| 20/10 Vision Care Optometry | |
|
2212 N. Lincoln Ave., Altadena, CA 91001 | |
| (626) 296-8416 | |
| (626) 389-5434 |
| Full Name | 20/10 Vision Care Optometry |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2212 N. Lincoln Ave., Altadena, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558618751 | NPI | - | NPPES |
| SD0108260 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 10826T (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| 20/10 Vision Care Optometry 2212 N. Lincoln Ave., Altadena, CA 91001 Ph: (626) 296-8416 | 20/10 Vision Care Optometry 2212 N. Lincoln Ave., Altadena, CA 91001 Ph: (626) 296-8416 |
News Archive
In a large study of men in Japan, the presence of fatty liver disease by ultrasonography showed an inverse ( reduced risk) association with the frequency of moderate alcohol consumption; however, there was some suggestion of an increase in fatty liver disease with higher volume of alcohol consumed per day.
Acupressure (applying pressure with the thumbs or fingertips to the same points on the body stimulated in acupuncture) seems to be more effective in reducing low back pain than physical therapy, finds a study published online by the British Medical Journal.
Oncolytics Biotech Inc. has announced that it has been granted its 31st U.S. Patent, # 7,476,382, entitled "Reovirus for the Treatment of Neoplasia." The patent includes claims to pharmaceutical compositions containing reovirus.
An examination of the 2013 guidelines for determining statin eligibility, compared to guidelines from 2004, indicates that they are associated with greater accuracy and efficiency in identifying increased risk of cardiovascular disease (CVD) events and presence of subclinical coronary artery disease, particularly in individuals at intermediate risk, according to a study in the July 14 issue of JAMA.
BrainStorm Cell Therapeutics Inc., an innovative developer of adult stem cell technologies and CNS therapeutics, today announced that patients from across the globe are demanding to be included in the pioneering clinical study started earlier this year at Jerusalem's Hadassah University Medical Center.
› Verified 3 days ago
Dr. Eileen Yi-ting Chang, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2212 N. Lincoln Ave., Altadena, CA 91001 Phone: 626-296-8416 |